{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-027196","form_type":"8-K","ticker":"ENVB","cik":"0000890821","company_name":"Enveric Biosciences, Inc.","filed_at":"2025-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.509602+00:00","generated_at":"2026-05-16T13:36:27.797877+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Enveric shareholders approve 50x increase in authorized shares and reverse split authority","bullets":["Approved increase in authorized common shares from 100M to 5B (50x) at board discretion.","Authorized reverse stock split at ratio between 1:5 and 1:15, with board to set exact ratio.","Issuance proposal to issue shares underlying warrants for Nasdaq Rule 5635 compliance passed.","Adjournment proposal rendered moot as quorum was achieved; all three proposals passed."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-027196","json":"https://secwatch.observer/filing/0001493152-25-027196.json","markdown":"https://secwatch.observer/filing/0001493152-25-027196.md","text":"https://secwatch.observer/filing/0001493152-25-027196.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/890821/000149315225027196/0001493152-25-027196-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/890821/000149315225027196/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:36:27.797877+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}